Remove 2024 Remove Cultivation Remove Hash Remove Patients
article thumbnail

Wyoming Cannabis Lobbyists Endeavor to Get Two Cannabis Initiatives Featured on 2024 Ballot

Veriheal

Now, pro-cannabis groups have their sights set on 2024. . There are two years still to go until the 2024 ballot takes place. Rather, the avid cannabis supporter stated that a January 2023 deadline would be more feasible to ensure that Wyoming’s legalization initiatives face a fair vote at the 2024 ballot.

article thumbnail

Europe’s Cannabis-Friendly Hotspots Could Trigger an Economic Shift 

Veriheal

In 2021, Luxembourg and Malta legalized home cannabis cultivation for personal use. In Germany, legal recreational cannabis sales are slated to launch by the end of 2024. On top of this, another controlled cannabis supply chain will roll out across Europe in 2024, but this time in the Netherlands. million patients by 2027.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Motley Fool Article: 5 Countries With the Highest Cannabis Spending by 2024

Cannabis Law Report

billion in cannabis spending by 2024. projects as the leading marijuana market in the world by sales in 2024. marijuana spending by 2024. billion by 2024. billion by 2024. billion by 2024. Of course, this production capacity is liable to be bumped up if patient demand merits it. billion by 2024.

article thumbnail

Marijuana tax rates: a state-by-state guide

SpeedWeed

For some medical patients in adult-use states, it can be easier to buy non-medical cannabis products and skip the hassle of getting or renewing a medical card. Additionally, dispensaries pay a 4% privilege tax when they purchase products from cultivators. . Medical marijuana: Purchases by patients are not subject to taxes.

article thumbnail

Recreational Cannabis Legalization in Germany? Medical Cannabis Businesses and Investors Hope So

Veriheal

Early success with medical cannabis has contributed to the market’s rising popularity among local German people, with up-to-date figures showing that at least 128,000 people have registered to receive cannabis-based medicines every single year under the patient program. What’s more, analysts foresee the market inflating to €7.7